1.08
price down icon2.26%   -0.025
 
loading
前日終値:
$1.105
開ける:
$1.1
24時間の取引高:
45,839
Relative Volume:
0.02
時価総額:
$4.82M
収益:
$72,100
当期純損益:
$-3.60M
株価収益率:
-0.9076
EPS:
-1.19
ネットキャッシュフロー:
$-3.37M
1週間 パフォーマンス:
-13.60%
1か月 パフォーマンス:
-13.25%
6か月 パフォーマンス:
+1.89%
1年 パフォーマンス:
-45.23%
1日の値動き範囲:
Value
$1.01
$1.10
1週間の範囲:
Value
$1.01
$1.2333
52週間の値動き範囲:
Value
$0.77
$4.50

Silo Pharma Inc Stock (SILO) Company Profile

Name
名前
Silo Pharma Inc
Name
セクター
Healthcare (1172)
Name
電話
(718) 400-9031
Name
住所
677 N. WASHINGTON BLVD, SARASOTA
Name
職員
3
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
SILO's Discussions on Twitter

SILO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
 icon
SILO
SILO PHARMA INC
1.71 17.96M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
19.95 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.16 304.74M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.265 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.25 142.54M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
10.50 141.55M 0 0 0 0.00

Silo Pharma Inc (SILO) 最新ニュース

pulisher
Mar 31, 2025

Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Increases By 38.7% - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Silo Pharma Inc. (SILO) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

Silo Pharma, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

SILO Stock Price and Chart — NASDAQ:SILO - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

Silo Pharma begins key study for PTSD treatment By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Doses First Participant In IND-Enabling GLP Study Of SPC-15 For PTSD Treatment - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma begins key study for PTSD treatment - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone With First Dosing In IND-Enabling GLP Study For SPC-15 As A Groundbreaking PTSD Treatment - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone with First Dosing in - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Major PTSD Treatment Advance: FDA Fast-Track Path Opens for Revolutionary Drug SPC-15 - Stock Titan

Mar 26, 2025
pulisher
Mar 10, 2025

Silo Pharma Unveils Strategic Initiatives and Drug Pipeline - TipRanks

Mar 10, 2025
pulisher
Mar 07, 2025

Silo Pharma secures patent for stress disorder prophylactic - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Silo Pharma secures patent for stress disorder prophylactic By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Feb 27, 2025

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

MarketsMedicine Hat News - Financial Content

Feb 27, 2025
pulisher
Feb 26, 2025

Silo Pharma Granted US Patent for Intranasal Post-Traumatic Stress Disorder Treatment - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Silo Pharma, Inc. Receives Issuance Notification for Patent Related to SPC-15 Treatment for PTSD - Nasdaq

Feb 26, 2025
pulisher
Feb 18, 2025

Silo Files Provisional Patent For SPC-15 Combination Treatment To Target Stress-Induced Disorders - Nasdaq

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment - The Manila Times

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for ... - The Bakersfield Californian

Feb 18, 2025
pulisher
Feb 18, 2025

Revolutionary Mental Health Treatment Patent: Silo Pharma's Dual-Action SPC-15 Shows Promising Results - StockTitan

Feb 18, 2025
pulisher
Feb 12, 2025

Silo Pharma reports positive early data on pain treatment implant By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma reports positive early data on pain treatment implant - Investing.com

Feb 11, 2025
pulisher
Feb 11, 2025

SILO’s valuation metrics: A comprehensive analysis - US Post News

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma's SP-26 Shows Promising Initial Safety And Absorption Data For Pain Relief - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma Reports Positive Safety Update from SP-26 Ketamine Implant Study with No Serious Side Effects Observed - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 - The Bakersfield Californian

Feb 11, 2025
pulisher
Feb 11, 2025

Revolutionary Pain Treatment: SILO's Ketamine Implant Aces Initial Safety Tests - StockTitan

Feb 11, 2025
pulisher
Feb 04, 2025

Monitoring SILO Pharma Inc (SILO) after recent insider movements - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

SILO Pharma Inc (SILO) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

SILO Pharma Inc’s Market Journey: Closing Strong at 1.79, Up 11.18 - The Dwinnex

Feb 04, 2025
pulisher
Jan 23, 2025

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment - GlobeNewswire

Jan 23, 2025
pulisher
Jan 22, 2025

Silo Pharma files provisional patent for PTSD treatment - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Silo Pharma Files Breakthrough PTSD Treatment Patent, Expands Columbia Tech Portfolio - StockTitan

Jan 22, 2025
pulisher
Jan 15, 2025

Looking For A Good Stock? Let This SILO Pharma Inc (NASDAQ: SILO) Analysis Help. - Stocks Register

Jan 15, 2025
pulisher
Jan 13, 2025

After A Patent Win, Analysts Think This Penny Stock Can Gain 465% In 2025 - Barchart

Jan 13, 2025
pulisher
Jan 10, 2025

Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 10, 2025
pulisher
Jan 09, 2025

Silo Pharma awarded U.S. patent for PTSD treatment - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

Silo Pharma secures patent for PTSD intranasal treatment By Investing.com - Investing.com Nigeria

Jan 09, 2025
pulisher
Jan 08, 2025

SILO Pharma flies high on impending patent for intranasal PTSD drug - Mugglehead

Jan 08, 2025
pulisher
Jan 08, 2025

Crude Oil Down 1%; US Weekly Jobless Claims Decline - Benzinga

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma shares soar on patent allowance news By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma shares soar on patent allowance news - Investing.com India

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma secures patent for PTSD intranasal treatment - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma Secures Key Patent Protection for PTSD Treatment SPC-15, Strengthens IP Portfolio - StockTitan

Jan 08, 2025

Silo Pharma Inc (SILO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Silo Pharma Inc (SILO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Weisblum Eric
CEO and President
Nov 20 '24
Buy
0.95
2,500
2,375
182,932
Weisblum Eric
CEO and President
Nov 22 '24
Buy
0.90
2,500
2,250
185,432
Weisblum Eric
CEO and President
Jun 12 '24
Buy
1.11
4,438
4,926
180,432
Weisblum Eric
CEO and President
Jun 11 '24
Buy
1.08
562
607
175,994
Weisblum Eric
CEO and President
Apr 05 '24
Buy
2.03
400
812
175,432
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):